2 unknown, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Cap: new trials by email Literature Review of Cap trials Research Report on Cap
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC Bevacizumab, 5-fluorouracil, Leucovorin calcium - Metastatic Colorectal Cancer | Phase 2 | Unknown | Chugai Pharmaceutical | 112 | 2019-10-11 | 2019-10-31 |
| The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater Cap - Ampulla of Vater Intestinal-Type Adenoma | Phase 2 | Unknown | Barretos Cancer Hospital | 120 | 2016-08-01 | 2016-08-18 |
| Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen CAP - Triple Negative Breast Cancer Patients | Phase 2 | Completed | Instituto Nacional de Cancer, Brazil | 41 | 2007-12-15 | 2017-10-25 |
Barretos Cancer Hospital (1) · Chugai Pharmaceutical (1) · Instituto Nacional de Cancer, Brazil (1)
Brazil (1) · Japan (1)
Akihito Tsuji, M.D., Ph.D. (1) · Otto Metzger, Oncologist (1) · Takeshi Kato, M.D., Ph.D. (1)
PMID 29416986, PMID 32646369, PMID 32703200, PMID 34019214, PMID 38901425